Return On Assets of Vanda Pharmaceuticals Inc. from 31 Mar 2012 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
- Summary
-
Vanda Pharmaceuticals Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2012 to 31 Dec 2025.
- Vanda Pharmaceuticals Inc. Return On Assets for the quarter ending 31 Dec 2025 was -38%, a 1195% decline year-over-year.
- Vanda Pharmaceuticals Inc. annual Return On Assets for 2025 was -38%, a 1195% decline from 2024.
- Vanda Pharmaceuticals Inc. annual Return On Assets for 2024 was -2.9%, a 845% decline from 2023.
- Vanda Pharmaceuticals Inc. annual Return On Assets for 2023 was 0.39%, a 62% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)
Vanda Pharmaceuticals Inc. Quarterly Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -38% | -35% | -1195% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -13% | -11% | -431% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -10% | -8.8% | -521% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -6.8% | -6.1% | -805% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -2.9% | -3.3% | -845% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -2.5% | -4.4% | -237% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -1.7% | -4% | -172% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -0.76% | -3.3% | -130% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | 0.39% | -0.63% | -62% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | 1.8% | +0.77% | +72% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | 2.3% | +0.5% | +27% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | 2.5% | -0.54% | -18% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | 1% | -4.8% | -82% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | 1.1% | -5.1% | -83% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | 1.8% | -4.2% | -69% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | 3.1% | -2.9% | -49% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | 5.8% | +1.2% | +27% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | 6.2% | +2.3% | +59% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | 6% | -17% | -74% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | 6% | -20% | -77% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | 4.6% | -23% | -83% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | 3.9% | -28% | -88% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | 23% | +15% | +180% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | 26% | +19% | +287% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | 27% | +20% | +245% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | 32% | +27% | +595% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | 8.3% | +7.8% | +1564% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | 6.6% | +8.7% | 01 Jan 2019 | 31 Mar 2019 | |
| Q4 2018 | 8% | +16% | 01 Oct 2018 | 31 Dec 2018 | |
| Q3 2018 | 4.6% | +11% | 01 Jul 2018 | 30 Sep 2018 | |
| Q2 2018 | 0.5% | +5.4% | 01 Apr 2018 | 30 Jun 2018 | |
| Q1 2018 | -2.1% | +4.4% | +68% | 01 Jan 2018 | 31 Mar 2018 |
| Q4 2017 | -7.5% | +1.2% | +13% | 01 Oct 2017 | 31 Dec 2017 |
| Q3 2017 | -6.9% | +8.6% | +56% | 01 Jul 2017 | 30 Sep 2017 |
| Q2 2017 | -4.9% | +15% | +75% | 01 Apr 2017 | 30 Jun 2017 |
| Q1 2017 | -6.4% | +13% | +67% | 01 Jan 2017 | 31 Mar 2017 |
| Q4 2016 | -8.7% | +9.6% | +52% | 01 Oct 2016 | 31 Dec 2016 |
| Q3 2016 | -16% | -37% | -172% | 01 Jul 2016 | 30 Sep 2016 |
| Q2 2016 | -20% | -50% | -164% | 01 Apr 2016 | 30 Jun 2016 |
| Q1 2016 | -19% | -46% | -173% | 01 Jan 2016 | 31 Mar 2016 |
| Q4 2015 | -18% | -36% | -204% | 01 Oct 2015 | 31 Dec 2015 |
| Q3 2015 | 22% | +75% | 01 Jul 2015 | 30 Sep 2015 | |
| Q2 2015 | 31% | +79% | 01 Apr 2015 | 30 Jun 2015 | |
| Q1 2015 | 27% | +59% | 01 Jan 2015 | 31 Mar 2015 | |
| Q4 2014 | 18% | +33% | 01 Oct 2014 | 31 Dec 2014 | |
| Q3 2014 | -53% | -39% | -261% | 01 Jul 2014 | 30 Sep 2014 |
| Q2 2014 | -48% | -34% | -226% | 01 Apr 2014 | 30 Jun 2014 |
| Q1 2014 | -32% | -15% | -89% | 01 Jan 2014 | 31 Mar 2014 |
| Q4 2013 | -16% | +2.3% | +13% | 01 Oct 2013 | 31 Dec 2013 |
| Q3 2013 | -15% | +1.3% | +8.3% | 01 Jul 2013 | 30 Sep 2013 |
| Q2 2013 | -15% | -1.1% | -7.7% | 01 Apr 2013 | 30 Jun 2013 |
| Q1 2013 | -17% | -7.5% | -79% | 01 Jan 2013 | 31 Mar 2013 |
| Q4 2012 | -18% | 01 Oct 2012 | 31 Dec 2012 | ||
| Q3 2012 | -16% | 01 Jul 2012 | 30 Sep 2012 | ||
| Q2 2012 | -14% | 01 Apr 2012 | 30 Jun 2012 | ||
| Q1 2012 | -9.5% | 01 Jan 2012 | 31 Mar 2012 |
Vanda Pharmaceuticals Inc. Annual Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -38% | -35% | -1195% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -2.9% | -3.3% | -845% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | 0.39% | -0.63% | -62% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | 1% | -4.8% | -82% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | 5.8% | +1.2% | +27% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | 4.6% | -23% | -83% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | 27% | +20% | +245% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | 8% | +16% | 01 Jan 2018 | 31 Dec 2018 | |
| 2017 | -7.5% | +1.2% | +13% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | -8.7% | +9.6% | +52% | 01 Jan 2016 | 31 Dec 2016 |
| 2015 | -18% | -36% | -204% | 01 Jan 2015 | 31 Dec 2015 |
| 2014 | 18% | +33% | 01 Jan 2014 | 31 Dec 2014 | |
| 2013 | -16% | +2.9% | +16% | 01 Jan 2013 | 31 Dec 2013 |
| 2012 | -18% | 01 Jan 2012 | 31 Dec 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.